Morgan Stanley
NYSE:MSFinancial - Capital Markets
+$0.33 today
- Market cap
- $285.76B
- Beta
- 1.22
- P/E (TTM)
- 19.5
- EPS (TTM)
- $11.57
- Dividend yield
- 1.78%
Volume 5.15M
Average 6.07M
MS Weighted Avg Shares (Diluted)
Average shares outstanding including dilutive securities, used to calculate diluted EPS.
Morgan StanleyNYSE: MS
Weighted Avg Shares (Diluted) · Q3 FY2026 · quarter ended Sep 2026
Weighted avg shares (diluted) declines year over year
Q3 FY2026 weighted avg shares (diluted) of 1.57B shares fell 1.7% year over year, behind the -0.8% change in trailing-twelve-month weighted avg shares (diluted). Sequentially, it fell 1.7% from the prior quarter. Over 3 fiscal years it compounded at -2.4% a year.
Context
- Weighted avg shares (diluted) increased in 0 of the last 3 fiscal years.
- FY2025 was the lowest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly growth recovers from -1.7% toward the trailing-twelve-month pace of -0.8%.
Sources:Income StatementText generated from reported figures; not investment advice.
Weighted Avg Shares (Diluted) history
Shares · from the income statement
- Latest · FY2025
- 1.59B USD
- Year-over-year change
- -1.1%
- 4-year CAGR
- -3.2%
| Period | Period end | Weighted Avg Shares (Diluted) | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 1.59B | -1.1% |
| FY2024 | 2024-12-31 | 1.61B | -2.1% |
| FY2023 | 2023-12-31 | 1.65B | -3.9% |
| FY2022 | 2022-12-31 | 1.71B | -5.6% |
| FY2021 | 2021-12-31 | 1.81B | — |
Weighted Avg Shares (Diluted) vs competitors
How MS compares with its peers on the latest reported figures
- MS's LTM Sep 2026 weighted avg shares (diluted) of 1.59B shares is the 9th highest of the 10 companies compared; the peer median is 3.03B shares.
- Its year-over-year change of -0.8% is the 3rd highest of 10, against a peer median of -3.5%.
- Over three fiscal years its annual growth of -2.4% compares with a peer median of -2.2%.
| Company | Period | LTM | YoY | 3-year CAGR |
|---|---|---|---|---|
| LTM Sep 2026 | 7.39B | -4.3% | -2.6% | |
| LTM Jun 2026 | 3.47B | -2.9% | -4.2% | |
| LTM Jun 2026 | 3.47B | +4.1% | -0.9% | |
| LTM Sep 2026 | 3.42B | -5.3% | -6.5% | |
| LTM Jun 2026 | 3.03B | -1.3% | -0.8% | |
| LTM Sep 2026 | 2.71B | -3.5% | -2.2% | |
| LTM Jun 2026 | 2.03B | +1.0% | -2.0% | |
| LTM Sep 2026 | 1.8B | -5.1% | -1.8% | |
| LTM Sep 2026 | 1.59B | -0.8% | -2.4% | |
| LTM Sep 2026 | 307.9M | -4.2% | -3.9% | |
| Peer median (excluding MS) | 3.03B | -3.5% | -2.2% | |
Competitors are the stored peer set for MS. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 57.78B | 62.48B | 88.29B | 103.15B | 114.98B |
| Cost of Revenue | 1.37B | 12.55B | 38.15B | 45.79B | 49.37B |
| Gross Profit | 56.41B | 49.93B | 50.14B | 57.36B | 65.62B |
| Gross Margin | 97.6% | 79.9% | 56.8% | 55.6% | 57.1% |
| Research & Development | 0 | 0 | 0 | 0 | 0 |
| Selling, General & Admin | 25.27B | 23.96B | 25.1B | 27.14B | 30.25B |
| Operating Expenses | 36.74B | 35.84B | 38.32B | 39.76B | 43.66B |
| Depreciation & Amortization | 4.22B | 4B | 4.26B | 5.16B | 4.66B |
| EBITDA | 23.88B | 18.09B | 16.07B | 22.76B | 26.61B |
| EBITDA Margin | 41.3% | 28.9% | 18.2% | 22.1% | 23.1% |
| Operating Income | 19.67B | 14.09B | 11.81B | 17.6B | 21.95B |
| Operating Margin | 34.0% | 22.6% | 13.4% | 17.1% | 19.1% |
| Interest Income | 9.41B | 21.6B | 45.85B | 54.14B | 59.06B |
| Interest Expense | 1.37B | 12.27B | 37.62B | 45.52B | 49.02B |
| Other Income / Expenses | 0 | 0 | 0 | 0 | 0 |
| Income Before Tax | 19.67B | 14.09B | 11.81B | 17.6B | 21.95B |
| Pre-Tax Margin | 34.0% | 22.6% | 13.4% | 17.1% | 19.1% |
| Income Tax Expense | 4.55B | 2.91B | 2.58B | 4.07B | 4.93B |
| Net Income | 15.03B | 11.03B | 9.09B | 13.39B | 16.86B |
| Net Margin | 26.0% | 17.7% | 10.3% | 13.0% | 14.7% |
| EPS (Basic) | 8.16 | 6.23 | 5.24 | 8.04 | 10.34 |
| EPS (Diluted) | 8.03 | 6.15 | 5.18 | 7.95 | 10.20 |
| Weighted Avg Shares | 1.79B | 1.69B | 1.63B | 1.59B | 1.57B |
| Weighted Avg Shares (Diluted) | 1.81B | 1.71B | 1.65B | 1.61B | 1.59B |
Morgan Stanley
NYSE:MS
Intrinsic Alpha fair value
Locked
Current Price
$181.17
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.